Neurology

An Update on Emerging S1P Therapeutics for the Management of Patients With Relapsing Multiple Sclerosis
http://academiccme.com/wp-content/uploads/2017/12/910746-125-x-125-wpcf_80x80.jpg
This CME program will highlight data presented at the 7th Annual Joint ECTRIMS – ACTRIMS Meeting in Paris, France…
Meeting Reporter
Clinical Trial Update: Therapeutic Strategies to Delay Disease Progression
http://academiccme.com/wp-content/uploads/2017/12/AD-Image_-Module-2-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. Marc E. Agronin, along with Dr. Richard S. Isaacson, course chair, will evaluate available therapeutic options for Alzheimer’s disease (AD) patient…
Webcast
Early Diagnosis and Disease Monitoring: Pathology and Biomarkers
http://academiccme.com/wp-content/uploads/2017/12/AD-Image_-Module-4-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. James E. Galvin, along with Dr. Richard S. Isaacson, course chair, will relay optimal strategies for early diagnosis of Alzheimer’s disease (AD)…
Webcast
Non-Pharmacological Approaches to Managing Patients With Alzheimer’s Disease
http://academiccme.com/wp-content/uploads/2017/12/AD-Image_-Module-3-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Max Lugavere, along with Dr. Richard S. Isaacson, course chair, will explore non-pharmacological approaches to managing patients with Alzheimer’s disease (AD)…
Webcast
The Role of Beta-Amyloid and Tau: CSF Protein Levels and PET Imaging
http://academiccme.com/wp-content/uploads/2017/12/AD-Image_-Module-1-wpcf_80x80.jpg
In this module of a Four-Part Expert Interview Series, Dr. Barry W. Rovner, along with Dr. Richard S. Isaacson, course chair, will provide learners with an update regarding beta-amyloid and tau biomarkers and their role in Alzheimer’s disease (AD) pathology and progression…
Webcast